Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1983 | 12-1982 | 12-1981 | 12-1980 | 12-1979 | |
| Sales | 2,927,873 | 2,602,447 | 2,342,524 | 2,038,155 | 1,717,979 |
| Cost of Goods | 1,517,629 | 1,420,471 | 1,299,405 | 1,143,392 | 959,564 |
| Gross Profit | 1,410,244 | 1,181,976 | 1,043,119 | 894,763 | 758,415 |
| Operating Expenses | 806,597 | 692,578 | 627,973 | 556,153 | 477,541 |
| Operating Income | 604,276 | 489,869 | 415,551 | 339,002 | 281,438 |
| Interest Expense | 77,589 | 69,493 | 77,428 | 51,520 | 41,110 |
| Other Income | 47,934 | 52,990 | 54,389 | 50,177 | 42,264 |
| Pre-tax Income | 574,621 | 473,366 | 392,512 | 337,659 | 282,592 |
| Income Tax | 227,004 | 184,243 | 145,229 | 123,246 | 100,393 |
| Net Income Continuous | 347,617 | 289,123 | 247,283 | 214,413 | 182,199 |
| Net Income | $347,617 | $289,123 | $247,283 | $214,413 | $182,199 |
| EPS Basic Total Ops | 0.18 | 0.15 | 0.13 | 0.11 | N/A |
| EPS Basic Continuous Ops | 0.18 | 0.15 | 0.13 | 0.11 | N/A |
| EPS Diluted Total Ops | 0.18 | 0.15 | 0.13 | 0.11 | N/A |
| EPS Diluted Continuous Ops | 0.18 | 0.15 | 0.13 | 0.11 | N/A |
| EBITDA(a) | $604,276 | $489,869 | $415,551 | $339,002 | $281,438 |